Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [177Lu]Lu-Satoreotide Tetraxetan and the Agonist [177Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST2-Positive Tumours
Plas, Pascale, Limana, Lorenzo, Carré, Denis, Thiongane, Amath, Raguin, Olivier, Mansi, Rosalba, Meyer-Losic, Florence, Lezmi, Stéphane
Published in Pharmaceuticals (Basel, Switzerland) (30.08.2022)
Published in Pharmaceuticals (Basel, Switzerland) (30.08.2022)
Get full text
Journal Article
Comparison of the Anti-Tumour Activity of the Somatostatin Receptor Antagonist [[sup.177]Lu]Lu-Satoreotide Tetraxetan and the Agonist [[sup.177]Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST[sub.2]-Positive Tumours
Plas, Pascale, Limana, Lorenzo, Carré, Denis, Thiongane, Amath, Raguin, Olivier, Mansi, Rosalba, Meyer-Losic, Florence, Lezmi, Stéphane
Published in Pharmaceuticals (Basel, Switzerland) (01.08.2022)
Published in Pharmaceuticals (Basel, Switzerland) (01.08.2022)
Get full text
Journal Article
Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer
Nakhlé, Jessica, Pierron, Valérie, Bauchet, Anne-Laure, Plas, Pascale, Thiongane, Amath, Meyer-Losic, Florence, Schmidlin, Fabien
Published in Oncoimmunology (02.06.2016)
Published in Oncoimmunology (02.06.2016)
Get full text
Journal Article